Suchergebnisse - "Inui, Y."

PubPharm (166)

1

508P Prognostic factors of soft tissue sarcoma (STS) treated with pazopanib from Nishinomiya Sarcoma Cohort Study (NSCS)

enthalten in: Annals of oncology | 2016

von Narahara, H. | Tanaka, E. | Morimoto, M. | +7

2

The real impact of telaprevir dosage on the antiviral and side effects of telaprevir, pegylated interferon and ribavirin therapy for chronic hepatitis C patients with HCV genotype 1

enthalten in: Journal of viral hepatitis | 2015

von Oze, T. | Hiramatsu, N. | Yakushijin, T. | +18

3

Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin

enthalten in: Journal of viral hepatitis | 2014

von Harada, N. | Hiramatsu, N. | Oze, T. | +21

4

Risk factors for hepatocellular carcinoma in hepatitis C patients with normal alanine aminotransferase treated with pegylated interferon and ribavirin

enthalten in: Journal of viral hepatitis | 2014

von Harada, N. | Hiramatsu, N. | Oze, T. | +21

5

Energetic analysis of SOFC co-generation system integrated with EV charging station installed in multifamily apartment

enthalten in: International journal of hydrogen energy | 2014

von Tanaka, T. | Kamiko, H. | Bando, T. | +4

6

Ant-repelling pollinators: Unique pollination strategy of the ant-plant Macaranga (Euphorbiaceae)

enthalten in: South African journal of botany | 2013

von Inui, Y. | Sakai, S.

7

Bound water restrained by nanocellulose fibres

enthalten in: Journal of thermal analysis and calorimetry | 2012

von Hatakeyama, T. | Inui, Y. | Iijima, M. | +1

8

Bound water restrained by nanocellulose fibres

enthalten in: Journal of thermal analysis and calorimetry | 2012

von Hatakeyama, T. | Inui, Y. | Iijima, M. | +1

9

306 Excessive MET Signaling Causes Acquired Resistance to and Addiction to MET Inhibitors in MKN45 Gastric Cancer Cell Line

enthalten in: The European journal of cancer / A | 2012

von Funakoshi, Y. | Mukohara, T. | Tomioka, H. | +7

10

Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin

enthalten in: Journal of viral hepatitis | 2009

von Hiramatsu, N. | Oze, T. | Yakushijin, T. | +25

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]